Estimates Revisions Monopar Therapeutics Inc.
Stocks
MNPR
US61023L2079
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.98 USD | +7.19% |
|
+38.99% | +46.14% |
| 11:16am | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to Russell 2000 Value Benchmark | CI |
| 09:31am | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to Russell Microcap Value Benchmark Index | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- MNPR Stock
- Consensus Monopar Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
